Landiolol, an ultra-short-acting β1-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: Prospective, multicenter, randomized, open-label study (JL-KNIGHT study)

Circulation Journal

Volumn 76, Issue 5, 2012, Pages 1097-1101

  Sakamoto, Atsuhiro ^a   Kitakaze, Masafumi ^b   Takamoto, Shinichi ^c   Namiki, Akiyoshi ^d   Kasanuki, Hiroshi ^e   Hosoda, Saichi ^f  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c MITSUI MEMORIAL HOSPITAL   (Japan)

^d Otaru City Hospital Bureau   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f SAKAKIBARA HEART INSTITUTE   (Japan)

Author keywords

Atrial fibrillation; Beta blocker; Cardiovascular surgery; Landiolol

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; LANDIOLOL;

ADULT; ARTICLE; BRADYCARDIA; COMPARATIVE STUDY; CONTINUOUS INFUSION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN HEART SURGERY; OPEN STUDY; PROSPECTIVE STUDY; SINUS RHYTHM;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; DILTIAZEM; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; UREA;

EID: 84860213480     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1332     Document Type: Article

References (19)

1. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061-1073.
2. Kinoshita T, Asai T, Nishimura O, Hiramatsu N, Suzuki T, Kambara A, et al. Statin for prevention of atrial fibrillation after off-pump coronary artery bypass grafting in Japanese patients. Circ J 2010; 74: 1846-1851.
3. Komatsu T, Tachibana H, Satoh Y, Ozawa M, Kunugita F, Tashiro A, et al. Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery. Circ J 2010; 74: 1859-1865.
4. Katoh T, Ohara T, Ogawa S, Kodama I. Multicenter survey on the validity of the CD-ROM guideline for antiarrhythmic drug therapy produced by the Japanese Circulation Society and the Japanese Society on Electrocardiology: Preliminary report of the survey of the Japanese guideline for Arrhythmia Management By Individual Therapy (J-GAMBIT). Circ J 2005; 69: 1357-1360.
5. Almassi GH, Sommers T, Moritz TE, Shroyer AL, London MJ, Henderson WG, et al. Stroke in cardiac surgical patients: Determinants and outcome. Ann Thorac Surg 1999; 68: 391-397.
6. Dunning J, Treasure T, Versteegh M, Nashef SA. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg 2006; 30: 852-872.
7. Balser JR, Martinez EA, Winters BD, Perdue PW, Clarke AW, Huang W, et al. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 1998; 89: 1052-1059.
8. Mooss AN, Wurdeman RL, Mohiuddin SM, Reyes AP, Sugimoto JT, Scott W, et al. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Am Heart J 2000; 140: 176-180.
9. Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 1999; 34: 70-77.
10. Ikeshita K, Nishikawa K, Toriyama S, Yamashita T, Tani Y, Yamada T, et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth 2008; 22: 361-366.
11. 1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 2010; 74: 856-863.
12. Wariishi S, Yamashita K, Nishimori H, Fukutomi T, Yamamoto M, Radhakrishnan G, et al. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: The efficacy of sustained intravenous infusion at a low dose. Interact Cardiovasc Thorac Surg 2009; 9: 811-813.
13. Fujiwara H, Sakurai M, Namai A, Kawamura T. Effect of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation after CABG surgery. Gen Thorac Cardiovasc Surg 2009; 57: 132-137.
14. Banach M, Kourliouros A, Reinhart KM, Benussi S, Mikhailidis DP, Jahangiri M, et al. Postoperative atrial fibrillation: What do we really know? Curr Vasc Pharmacol 2010; 8: 553-572.
15. Workman AJ. Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2010; 381: 235-249.
16. Hilleman DE, Reyes AP, Mooss AN, Packard KA. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery. Curr Med Res Opin 2003; 19: 376-382.
17. Sticherling C, Tada H, Hsu W, Bares AC, Oral H, Pelosi F, et al. Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation. J Cardiovasc Pharmacol Ther 2002; 7: 81-88.
18. Chauhan S, Saxena N, Rao BH, Singh RS, Bhan A. A comparison of esmolol and diltiazem for heart rate control during coronary revascularization on beating heart. Ann Card Anaesth 2000; 3: 28-31.
19. Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial. J Thorac Cardiovasc Surg 2011; 141: 1478-1487.